Gertz MA - Search Results

1

Waldenstrom Macroglobulinemia: Tailoring Therapy for the Individual.

Gertz MA. Gertz MA. J Clin Oncol. 2022 Aug 10;40(23):2600-2608. doi: 10.1200/JCO.22.00495. Epub 2022 Jun 14. J Clin Oncol. 2022. PMID: 35700418 Free PMC article. Review.

2

Waldenström's macroglobulinemia: a review of therapy.

Gertz MA. Gertz MA. Leuk Lymphoma. 2002 Aug;43(8):1517-26. doi: 10.1080/1042819021000002839. Leuk Lymphoma. 2002. PMID: 12400593 Review.

3

Combination therapy with thalidomide plus dexamethasone for newly diagnosed myeloma.

Rajkumar SV, Hayman S, Gertz MA, Dispenzieri A, Lacy MQ, Greipp PR, Geyer S, Iturria N, Fonseca R, Lust JA, Kyle RA, Witzig TE. Rajkumar SV, et al. Among authors: gertz ma. J Clin Oncol. 2002 Nov 1;20(21):4319-23. doi: 10.1200/JCO.2002.02.116. J Clin Oncol. 2002. PMID: 12409330 Clinical Trial.

4

Treatment recommendations in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.

Gertz MA, Anagnostopoulos A, Anderson K, Branagan AR, Coleman M, Frankel SR, Giralt S, Levine T, Munshi N, Pestronk A, Rajkumar V, Treon SP. Gertz MA, et al. Semin Oncol. 2003 Apr;30(2):121-6. doi: 10.1053/sonc.2003.50039. Semin Oncol. 2003. PMID: 12720120 Review.

5

Amyloidosis with IgM monoclonal gammopathies.

Gertz MA, Kyle RA. Gertz MA, et al. Semin Oncol. 2003 Apr;30(2):325-8. doi: 10.1053/sonc.2003.50060. Semin Oncol. 2003. PMID: 12720162

6

Waldenström macroglobulinaemia.

Ghobrial IM, Gertz MA, Fonseca R. Ghobrial IM, et al. Among authors: gertz ma. Lancet Oncol. 2003 Nov;4(11):679-85. doi: 10.1016/s1470-2045(03)01246-4. Lancet Oncol. 2003. PMID: 14602248 Review.

7

Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosis.

Dispenzieri A, Gertz MA, Kyle RA, Lacy MQ, Burritt MF, Therneau TM, Greipp PR, Witzig TE, Lust JA, Rajkumar SV, Fonseca R, Zeldenrust SR, McGregor CG, Jaffe AS. Dispenzieri A, et al. Among authors: gertz ma. J Clin Oncol. 2004 Sep 15;22(18):3751-7. doi: 10.1200/JCO.2004.03.029. J Clin Oncol. 2004. PMID: 15365071

8

Multicenter phase 2 trial of rituximab for Waldenström macroglobulinemia (WM): an Eastern Cooperative Oncology Group Study (E3A98).

Gertz MA, Rue M, Blood E, Kaminer LS, Vesole DH, Greipp PR. Gertz MA, et al. Leuk Lymphoma. 2004 Oct;45(10):2047-55. doi: 10.1080/10428190410001714043. Leuk Lymphoma. 2004. PMID: 15370249 Clinical Trial.

9

Initial immunoglobulin M 'flare' after rituximab therapy in patients diagnosed with Waldenstrom macroglobulinemia: an Eastern Cooperative Oncology Group Study.

Ghobrial IM, Fonseca R, Greipp PR, Blood E, Rue M, Vesole DH, Gertz MA; Eastern Cooperative Oncology Group. Ghobrial IM, et al. Among authors: gertz ma. Cancer. 2004 Dec 1;101(11):2593-8. doi: 10.1002/cncr.20658. Cancer. 2004. PMID: 15493038 Free article. Clinical Trial.

10

Initial increase in the cryoglobulin level after rituximab therapy for type II cryoglobulinemia secondary to Waldenström macroglobulinemia does not indicate failure of response.

Ghobrial IM, Uslan DZ, Call TG, Witzig TE, Gertz MA. Ghobrial IM, et al. Among authors: gertz ma. Am J Hematol. 2004 Dec;77(4):329-30. doi: 10.1002/ajh.20207. Am J Hematol. 2004. PMID: 15551276 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

954 results

Search Page

Filters